Indometacin Market

The global Indometacin (Indomethacin) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global Indometacin (Indomethacin) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Indometacin (Indomethacin) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Indometacin (Indomethacin) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Indometacin, or indomethacin, is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic properties. NSAIDs consist of agents that are structurally unrelated; the NSAID chemical classification of indometacin is an indole-acetic acid derivative with the chemical name 1- (p-chlorobenzoyl)25-methoxy-2-methylindole-3-acetic acid.The pharmacological effect of indometacin is not fully understood, however, it is thought to be mediated through potent and nonselective inhibition of the enzyme cyclooxygenase (COX), which is the main enzyme responsible for catalyzes the rate-limiting step in prostaglandin and thromboxane biosynthesis via the arachidonic acid (AA) pathway.
Indometacin Market aims to provide a comprehensive presentation of the global market for Indometacin (Indomethacin), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Indometacin (Indomethacin).

Indometacin Market contains market size and forecasts of Indometacin (Indomethacin) in global, including the following market information:

• Global Indometacin (Indomethacin) Market Revenue, 2018-2023, 2024-2030, ($ millions)
• Global top five companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Indometacin (Indomethacin) include Iroko Pharma, Zyla Life Sciences, Kowa, Merck, H. Lumdbeck, Recordati, Druggability Technologies, AlphaRx and Cypress Bioscience, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Indometacin (Indomethacin) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Indometacin (Indomethacin) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Indometacin (Indomethacin) Market Segment Percentages, by Type, 2022 (%)

• Tablet
• Capsule
• Suppository
• Injection
• Patch
• Gelatin Pearl
• Cream
• Other

Global Indometacin (Indomethacin) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Indometacin (Indomethacin) Market Segment Percentages, by Application, 2022 (%)

To know more about market statistics, Download a FREE Sample copy

• Nonsteroidal Anti-Inflammatory Drugs
• Topical Administration For Joint And Muscle Pain
• Western Medicine Carcinogenic Pain Medicine
• Dysmenorrheal
• Batter Syndrome
• Other

Global Indometacin (Indomethacin) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Indometacin (Indomethacin) Market Segment Percentages, By Region and Country, 2022 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Indometacin (Indomethacin) revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Indometacin (Indomethacin) revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Iroko Pharma
• Zyla Life Sciences
• Kowa
• Merck
• H. Lumdbeck
• Recordati
• Druggability Technologies
• AlphaRx
• Cypress Bioscience
• NAL Pharma
• Dr. Reddy?s
• Provalis
• NIPRO
• Shanghai Modern Pharmaceutical
• Beijing Shuangji Pharmaceutical
• Sinopharm Group Industry
• Jiangsu Yuanheng Pharmaceutical
• Hubei Dongxin Pharmaceutical
• Ma Yinglong Pharmaceutical Group
• Shanghai New Yellow River Pharmaceutical Co. , Ltd.
• JBH Pharmaceutical Group
• Linfen Baozhu Pharmaceutical
• Shanxi Yunpeng Pharmaceutical
• Shanxi Taiyuan Pharmaceutical
• Guangdong Sancai Shiqi District Pharmaceutical
• Guangdong South China Pharmaceutical Group
• Jiangsu Yabang Aipusen Pharmaceutical
• Chongqing Kerui Pharmaceutical Group
• Beijing Honglin Pharmaceutical
• Suzhou No. 3 Pharmaceutical Factory
• Bedford Pharma
• Northwind Pharmaceuticals
• PD-Rx Pharmaceuticals

Outline of Major Chapters:
Chapter 1: Introduces the definition of Indometacin (Indomethacin), market overview.
Chapter 2: Global Indometacin (Indomethacin) market size in revenue.
Chapter 3: Detailed analysis of Indometacin (Indomethacin) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Indometacin (Indomethacin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.